Last reviewed · How we verify

NCT06073054

A Pharmacist Intervention to Improve Mother and Child Health

Completed NA Results posted Last updated 29 August 2025
What this trial tests

NA trial testing Research Pharmacist in Hypertension in 25 participants. Completed in 10 July 2024.

Timeline
30 January 2024
Primary endpoint
10 July 2024
10 July 2024

Quick facts

Lead sponsorUniversity of Iowa
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposescreening
Enrollment25
Start date30 January 2024
Primary completion10 July 2024
Estimated completion10 July 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Iowa

Who can join

Adults 18 to 55, female only, with Hypertension. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Number of Participants Who Talk to Research Pharmacist Primary · Through study completion, an average of 30 days

We will calculate the number of participants who talk to the research pharmacist during the course of the intervention.

GroupValue95% CI
Research Pharmacist Monitoring20
Number of Participants Who Return BP Measurements Primary · Through study completion, an average of 30 days

We will calculate the number of participants who return at least one blood pressure measurement via text message.

GroupValue95% CI
Research Pharmacist Monitoring22
Percentage of Well-Child Visits Attended Primary · Through study completion, an average of 30 days

We will calculate the percentage of well-child visits that are attended by each family.

GroupValue95% CI
Research Pharmacist Monitoring57
Percentage of Vaccinations Received Primary · Through study completion, an average of 30 days

We will calculate the percentage of vaccinations received by each child.

GroupValue95% CI
Research Pharmacist Monitoring251
Number of BP Measurements Submitted Secondary · Through study completion, an average of 30 days

We will calculate the number of blood pressure values that are submitted by each participant.

GroupValue95% CI
Research Pharmacist Monitoring12.9± 5.3
Blood Pressure Control Secondary · Through study completion, an average of 30 days

We will determine how many participants' blood pressure is controlled after the intervention.

GroupValue95% CI
Research Pharmacist Monitoring12
Number of Participants Satisfied With the Study Secondary · Through study completion, an average of 30 days

We will measure participant satisfaction with the study using an exit survey. Satisfaction will be measured by a response of Extremely Helpful or Helpful on the question- My contact(s) with the pharmacist about my health were....

GroupValue95% CI
Research Pharmacist Monitoring7

Sponsor's own description

The goal of this clinical trial is to learn if a research pharmacist can improve the health of new mothers and their babies. The main questions it aims to answer are: * Will postpartum women who had elevated blood pressure during pregnancy be willing to participate in the study, talk to a pharmacist about their health and the health of their child, and text us their blood pressure measurements? * Will contact with the pharmacist improve the health of the mother and/or the child? Participants will: * complete a baseline demographic survey, * be given a blood pressure cuff and taught how to use it, * be asked to text us their blood pressure values 2 times per day for 7 days after enrollment, * complete a phone call with a pharmacist discussing their health and the health of their baby, * text us their blood pressure 1 time per day for 3 days 1 month after enrollment, * have a 1 month follow-up phone call with the research pharmacist, and * complete an exit survey to provide feedback about the study.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Hypertension

Currently open trials in the same condition.

Other University of Iowa trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06073054.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing